Thyroid tumors : Studies in animals showed a small risk, and while its rare in people, its something to discuss with your doctor
Or, they may require another dosage, ingredient mix, or formulation
Someone who has run a single GLP-1 compound, hit a wall around month four, and wants to push past it is close to the ideal candidate, because the amylin pathway addresses exactly the satiety gap that tends to reopen at that stage
Its crucial for marketers and retailers to develop a deep understanding of the emerging preferences of these shoppers that goes well-beyond low-calorie solutions, said Jeff Perry, VP, CPG Omni-Channel Solutions at Catalina, which has developed a GLP-1 Friendly shopper persona to provide purchase-based insights into this growing audience